Luke Rhodes

Long Snapper

Age: 32
Free Agency: 2028 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $1,430,000 (0.55% of cap)
  • 2024 Cash Payout: $1,210,000 (0.47% of spending)
  • 2024 Cash to Cap Ratio: 0.85
  • Contract Value: $6,465,000 ($1,616,250 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 1/35 at LS

Current Contract

(Extension, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202331$1,200,000$220,000$0$1,200,000$1,420,0000.6%
202432$1,210,000$220,000$0$200,000$1,430,0000.5%
202533$1,255,000$220,000$85,000$0$1,475,0000.5%
202634$1,300,000$220,000$85,000$0$1,520,0000.5%
202735$1,345,000$220,000$85,000$0$1,565,0000.5%
Total$6,310,000$1,100,000$255,000$1,400,000$7,410,000

Contract Notes

Luke Rhodes signed a 4 year extension with the Indianapolis Colts on September 8, 2023 worth $6,465,000 with $2.5 million in total guarantees including a $1.1 million signing bonus.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
$1.6M
$3.2M
$4.8M
$6.5M
Old Money20232024202520262027
Cash Due$255,000$1,100,000$1,210,000$1,255,000$1,300,000$1,345,000
Running Cash$1,355,000$2,565,000$3,820,000$5,120,000$6,465,000
Career Earnings: $8,144,982
Career APY: $1,018,123
Potential Earnings: $13,190,882
Total Guarantees: $1,250,000
Largest Cash Payment: $2,300,000 (2023)
Largest Cap Number: $1,570,000 (2019)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
ColtsSFAExpired20162$990,000$495,000$0$645,88265.2%$322,941
ColtsERFAExpired20181$630,000$630,000$0$630,000100.0%$630,000
ColtsERFARenegotiated20191$720,000$720,000$0$00.0%$0
ColtsExtensionRenegotiated20194$4,850,000$1,212,500$1,250,000$4,505,00092.9%$1,126,250
ColtsExtensionActive20234$6,465,000$1,616,250$0$2,300,00035.6%$2,300,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Colts8$8,142,982$1,017,873$7,200,8820.0%$62,1000.0%
Buccaneers$2,000$0$00.0%$2,0000.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2016Colts$450,000$0$0$0$0$105,8820.1%$105,882
2017Colts$540,000$0$0$0$0$540,0000.3%$540,000
2018Colts$630,000$0$0$0$0$630,0000.3%$630,000
2019Colts$720,000$0$850,000$0$400,000$1,570,0000.7%$1,570,000
2020Colts$910,000$0$0$0$0$910,0000.4%$910,000
2021Colts$990,000$0$0$0$0$990,0000.5%$990,000
2022Colts$1,035,000$0$0$0$0$1,035,0000.5%$1,035,000
2023Colts$1,200,000$220,000$0$0$1,200,000$1,420,0000.6%$2,300,000
2024Colts$1,210,000$220,000$0$0$200,000$1,430,0000.5%$1,210,000
2025Colts$1,255,000$220,000$0$85,000$0$1,475,0000.5%$1,255,000
2026Colts$1,300,000$220,000$0$85,000$0$1,520,0000.5%$1,300,000
2027Colts$1,345,000$220,000$0$85,000$0$1,565,0000.5%$1,345,000
Total$11,585,000$1,100,000$850,000$255,000$1,800,000$13,190,882$13,190,882
Dead Money History
TeamYearCap ChargeCash Paid
Buccaneers2016$666$2,000
Colts2016$62,100$62,100
Buccaneers2017$1,334$0
Total$64,100$64,100

Statistics

YearGames PlayedGames InactiveSnaps
InjuredHealthySpecial
201640010.3%
2017160032.4%
2018160030.9%
2019160030.9%
2020150029.5%
2021160032.2%
2022170029.7%
2023170030.3%
202440030.9%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$680,000$1,616,250
Injury Adjusted$680,000$1,616,250
test
OTC Valuation $201.7k $403.3k $605k $806.7k $1M APY $269.4k $538.8k $808.1k $1.1M $1.3M $913,000 $1,320,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.